Deferred Income Tax Assets, Net in USD of HAEMONETICS CORP from Q1 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
Summary
HAEMONETICS CORP quarterly Deferred Income Tax Assets, Net history and change rate from Q1 2019 to Q3 2025.
  • HAEMONETICS CORP Deferred Income Tax Assets, Net for the quarter ending 27 Sep 2025 was $7.57M, a 16.6% decline year-over-year.
Deferred Income Tax Assets, Net, Quarterly (USD)
Deferred Income Tax Assets, Net, YoY Quarterly Change (%)

HAEMONETICS CORP Quarterly Deferred Income Tax Assets, Net (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $7.57M -$1.51M -16.6% 27 Sep 2025 10-Q 06 Nov 2025
Q2 2025 $7.84M -$1.53M -16.3% 28 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $7.8M +$64K +0.83% 29 Mar 2025 10-Q 06 Nov 2025
Q4 2024 $8M +$2.93M +57.8% 28 Dec 2024 10-Q 06 Feb 2025
Q3 2024 $9.08M +$4.34M +91.4% 28 Sep 2024 10-Q 07 Nov 2024
Q2 2024 $9.37M +$4.49M +92.2% 29 Jun 2024 10-Q 08 Aug 2024
Q1 2024 $7.74M +$2.5M +47.7% 30 Mar 2024 10-K 21 May 2025
Q4 2023 $5.07M +$228K +4.71% 30 Dec 2023 10-Q 08 Feb 2024
Q3 2023 $4.75M +$463K +10.8% 30 Sep 2023 10-Q 02 Nov 2023
Q2 2023 $4.88M +$323K +7.1% 01 Jul 2023 10-Q 08 Aug 2023
Q1 2023 $5.24M +$773K +17.3% 01 Apr 2023 10-K 20 May 2024
Q4 2022 $4.84M -$1.21M -20% 31 Dec 2022 10-Q 07 Feb 2023
Q3 2022 $4.28M -$1.78M -29.4% 01 Oct 2022 10-Q 08 Nov 2022
Q2 2022 $4.55M -$1.65M -26.5% 02 Jul 2022 10-Q 10 Aug 2022
Q1 2022 $4.47M -$1.54M -25.6% 02 Apr 2022 10-K 22 May 2023
Q4 2021 $6.05M +$1.49M +32.7% 01 Jan 2022 10-Q 08 Feb 2022
Q3 2021 $6.06M +$1.76M +40.8% 02 Oct 2021 10-Q 09 Nov 2021
Q2 2021 $6.2M +$2.11M +51.6% 03 Jul 2021 10-Q 11 Aug 2021
Q1 2021 $6.01M +$2.08M +52.9% 03 Apr 2021 10-K 25 May 2022
Q4 2020 $4.56M 26 Dec 2020 10-Q 02 Feb 2021
Q3 2020 $4.31M 26 Sep 2020 10-Q 04 Nov 2020
Q2 2020 $4.09M 27 Jun 2020 10-Q 04 Aug 2020
Q1 2020 $3.93M -$429K -9.84% 28 Mar 2020 10-K 26 May 2021
Q1 2019 $4.36M 30 Mar 2019 10-K 20 May 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.